UBERDOC Health Technologies Announces Appointment of John Dvor to Board of Directors
Board Appointment Enhances UberDoc's Strategic Positioning in the Rapidly Growing Direct-Pay Healthcare Market
Boston, Massachusetts--(Newsfile Corp. - May 19, 2026) - UBERDOC Health Technologies (CSE: APPT) (FSE: 4KL0) is pleased to announce the appointment of John Dvor to its Board of Directors as the company continues to scale its nationwide direct-pay specialty care marketplace and expand strategic partnerships in advanced medical services and technologies.
John Dvor brings deep experience and extensive relationships across medical innovation, healthcare technology, advanced therapeutics, cancer care, longevity medicine, and pharmacogenetics – particularly within the rapidly growing direct-pay healthcare sector. His background includes roles with C10 Labs, an AI venture studio and accelerator with deep ties to the MIT innovation ecosystem, executive leadership at SS Innovations International (NASDAQ: SSII), a publicly traded medical technology company with an approximate US$1 billion market valuation, and healthcare venture leadership as co-founder of Tufts Health Ventures, including exposure to disruptive care delivery models such as Iora Health, later acquired by Amazon as part of One Medical. A U.S. Marine Corps veteran who served in the White House Military Office, he is also a graduate of Harvard University.
"I was an avid early supporter of Dr. Paula Muto and UberDoc," said John Dvor. "I'm honored to serve as Director as the company scales direct patient-to-physician appointments and adds innovative protocols and products to better serve members."
Founded by Dr. Paula Muto, a practicing surgeon, UberDoc is one of the nation's largest direct-pay specialty care networks, connecting patients directly with board-certified specialists for transparent, affordable appointments without referrals, prior authorizations, or insurance restrictions. The web-based platform enables patients to search, book, and pay for appointments directly, restoring access and simplicity to specialty care.
As the company expands nationally following its public listing, UberDoc is positioning itself as a leading marketplace for healthcare services delivered outside the traditional insurance model. In addition to specialty physician appointments, the platform is building strategic partnerships that offer direct-pay solutions in areas including advanced diagnostics, longevity protocols, pharmacogenetics, therapeutics, imaging, and surgical services.

